1. Roche sues Pfizer to prevent a biosimilar from entering US market
Roche Holding AG sued Pfizer in a move to prevent a biosimilar version of its breast cancer drug Herceptin from entering the U.S. market.
2. Sun Pharma recalls diabetes drug due to fungal contamination
Sun Pharmaceutical Industries recalled two lots of the diabetes drug Riomet over contamination issues.
3. Gilead launches hepatitis drug in China at one-fifth the US price
Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., launched its hepatitis C drug in China with a price tag significantly lower than in the U.S.
4. Amazon in ‘exploratory talks’ with Mylan, Novartis, other generic drugmakers
Amazon has reportedly held preliminary discussions with several generic drug manufacturers regarding the company’s potential foray into the pharmacy business.
5. Sanofi halts C. diff vaccine production
Sanofi, a French pharmaceutical company, halted the development and production of an experimental Clostridium difficile vaccine Friday after preliminary results of a late-stage trial revealed a low probability for success.
More articles on supply chain:
FDA: Biotin supplements may interfere with lab tests
Gilead launches hepatitis drug in China at one-fifth the US price
CVS launches ‘real-time benefits’ tool to increase price transparency
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
